Published in J Clin Immunol on March 01, 1992
Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A (1996) 3.78
Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res (2010) 1.17
Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol (2012) 1.06
Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol (1999) 1.01
Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol (2008) 1.00
Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia. Clin Exp Immunol (2002) 0.98
Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis. Clin Diagn Lab Immunol (1996) 0.97
Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare. Clin Exp Immunol (2009) 0.95
Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis. Blood (2015) 0.93
Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome. Clin Exp Immunol (2003) 0.90
Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients. Clin Exp Immunol (2014) 0.81
Novel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasia. Clin Exp Immunol (2001) 0.80
Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT). Clin Exp Immunol (2000) 0.79
Role of Nijmegen breakage syndrome protein in specific T-lymphocyte activation pathways. Clin Diagn Lab Immunol (2001) 0.76
Unravelling the web of DNA repair disorders. Clin Exp Immunol (2003) 0.75
JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett (1997) 3.41
Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med (1990) 2.69
Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood (1993) 2.59
Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53
The immunology of exceptional individuals: the lesson of centenarians. Immunol Today (1995) 2.26
Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. Clin Infect Dis (1999) 2.17
Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) (2000) 2.09
Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol (1993) 2.02
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Control of apoptosis by the cellular ATP level. FEBS Lett (1996) 1.75
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol (2000) 1.70
Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet (1992) 1.68
Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance. Radiology (1995) 1.62
Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci U S A (1996) 1.56
Impaired production of interleukins in patients with cell-mediated immunodeficiencies. Clin Exp Immunol (1983) 1.55
The aging thyroid. Endocr Rev (1995) 1.53
Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol (1985) 1.52
Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes. Clin Exp Immunol (1973) 1.46
Maize food allergy: a double-blind placebo-controlled study. Clin Exp Allergy (2008) 1.45
Plasma viraemia in seronegative HIV-1-infected individuals. AIDS (1991) 1.43
Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res (2000) 1.40
Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev (2008) 1.34
Cytofluorimetric identification of two populations of double positive (CD4+,CD8+) T lymphocytes in human peripheral blood. Biochem Biophys Res Commun (1993) 1.34
CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev (1996) 1.30
Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy (1995) 1.26
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24
Surface markers on lymphocytes of patients with infectious diseases. Infect Immun (1973) 1.21
Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol (1995) 1.19
Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev (2000) 1.17
CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med (1995) 1.16
Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis (1995) 1.16
Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS). Clin Exp Immunol (1987) 1.15
Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol (1998) 1.11
Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol (1992) 1.11
Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol (1999) 1.11
Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin Exp Immunol (1991) 1.10
Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J Gen Virol (2001) 1.10
Metastatic metanephric adenoma with foci of papillary carcinoma in a child: a combined histologic, immunohistochemical, and FISH study. Int J Surg Pathol (2001) 1.09
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS (1999) 1.08
Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. Am J Med Genet (1988) 1.06
Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood (1991) 1.06
Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Exp Cell Res (1998) 1.05
Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies. Clin Exp Immunol (1973) 1.05
C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol (1997) 1.05
Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today (1990) 1.04
Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol (1988) 1.04
Gastric pathology in patients with common variable immunodeficiency. Gut (1999) 1.04
TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood (1995) 1.03
Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol (2002) 1.03
Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.02
A patient with nucleoside phosphorylase deficiency, selective t-cell deficiency, and autoimmune hemolytic anemia. J Pediatr (1978) 1.02
Hepatitis C virus antibodies in gammaglobulin. Lancet (1990) 1.01
Identification of actinidin as the major allergen of kiwi fruit. J Allergy Clin Immunol (1998) 1.01
Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl (1990) 1.01
CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Clin Exp Immunol (1999) 1.00
Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett (1998) 1.00
Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy (2008) 1.00
Mitochondrial membrane potential and DNA stainability in human sperm cells: a flow cytometry analysis with implications for male infertility. Exp Cell Res (1998) 1.00
Nonfebrile seizures after febrile convulsions: possible role of chronic cytomegalovirus infection. J Pediatr (1982) 1.00
Patterns of covariation of DSM-IV personality disorders in a mixed psychiatric sample. Compr Psychiatry (2000) 0.99
Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol (2001) 0.98
Function and distribution pattern of human T lymphocytes. II. Presence of T lymphocytes in normal humans and in humans with various immunodeficiency disorders. Clin Exp Immunol (1973) 0.98
Complement activation is associated with the presence of specific human immunodeficiency virus (HIV)-anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome. Scand J Immunol (1989) 0.98
Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood (1997) 0.97
Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol (1994) 0.97
Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity. Ann Rheum Dis (1993) 0.97
Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III. J Interferon Res (1986) 0.97
IgG subclasses to group B streptococci in normals, colonized woman and IgG2 subclass-deficient patients. Monogr Allergy (1988) 0.96
Protein A-positive staphylococci serve as a selective B cell mitogen for lymphocytes from primary immunodeficiency patients. Clin Exp Immunol (1979) 0.96
Recovery of human lymphocytes damaged with gamma-radiation or enzymatically produced oxygen radicals: different effects of poly(ADP-ribosyl)polymerase inhibitors. Int J Radiat Biol (1990) 0.95
Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod (1996) 0.95
Ovomucoid (Gal d 1) specific IgE detected by microarray system predict tolerability to boiled hen's egg and an increased risk to progress to multiple environmental allergen sensitisation. Clin Exp Allergy (2011) 0.95
Hepatoma HepG2 cells as a model for in vitro studies on mitochondrial toxicity of antiviral drugs: which correlation with the patient? J Biol Regul Homeost Agents (2003) 0.95
Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J Acquir Immune Defic Syndr (1992) 0.95
Delayed appearance of HIV infection in children. Lancet (1987) 0.95
Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum in parasite-host cell interactions. Parassitologia (1993) 0.95
Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology (1986) 0.95
T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol (2000) 0.94
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART. Clin Immunol (2000) 0.94
Familial lymphopenia with T lymphocyte defect. J Pediatr (1974) 0.94
Interferon production in primary immunodeficiencies. J Clin Immunol (1984) 0.94
Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J Clin Immunol (1983) 0.93
Identification of a novel sequence at the 3' end of the GB virus B genome. J Virol (1999) 0.93
Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat (2003) 0.93